S-ICD associated with 92 percent reduction in lead-related complications typical in patients with ICDs
Medical Xpress
NOVEMBER 8, 2022
The randomized multicenter ATLAS trial of more than 500 persons has found that subcutaneous implantable cardioverter defibrillators (S-ICDs) reduce perioperative, lead-related complications without significantly compromising the effectiveness of ICD shocks, but with more early postoperative pain and a trend for more inappropriate shocks.
Let's personalize your content